Mohamed Taha

10PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular medicineMedical infection agents (incl. prions)Gene and molecular therapyNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2026
Tissue expression profiles of miR-6809 and miR-4753 in triple-negative breast cancer: Novel biomarkers of early detection and staging.

|May 11, 2026
Dexmedetomidine and Apigenin Combination Mitigates Memory Deficits Caused by Microglial Activation and Hippocampal Neurogenesis Impairment in Methotrexate-Induced Chemo-Brain in Rats.

|Mar 21, 2023
Apigenin Attenuates Hippocampal Microglial Activation and Restores Cognitive Function in Methotrexate-Treated Rats: Targeting the miR-15a/ROCK-1/ERK1/2 Pathway.

Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei

|Jan 08, 2023
Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation.

Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei

|Nov 02, 2021
Author Correction: Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson's disease rat model.

Omar A Ahmed-Farid, Mohamed Taha, Rofanda M Bakeer

|Oct 28, 2021
Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson's disease rat model.

Omar A Ahmed-Farid, Mohamed Taha, Rofanda M Bakeer

Pageof 2

Frequent Collaborators

4 joint publications

Einas Yousef

2 joint publications

Noha Mitwally

2 joint publications

Omar Mohsen Eldemerdash

2 joint publications

Mahmoud A Senousy